Market
What will be the outcome of the vaccine safety review by June 2025?
2
Resolution / Starting Odds
No changes recommended • 25%
Some vaccines recommended for elimination • 25%
Enhanced safety protocols recommended • 25%
Comprehensive overhaul of vaccine policies • 25%
Official report or announcement from the US Department of Health and Human Services
Story
Trump Orders Vaccine Safety Review Amid Polio Vaccine Controversy
Dec 13, 2024, 07:00 PM
President-elect Donald Trump has announced a comprehensive review of several vaccines, led by Robert F. Kennedy Jr., his nominee for Secretary of Health and Human Services (HHS). This review aims to ensure the safety of vaccines, with Trump expressing confidence in Kennedy's expertise on health issues. Kennedy, known for his skepticism towards vaccines, has been involved in discussions about potentially eliminating some vaccines, including the polio vaccine, due to concerns over their safety and efficacy. His advisor, Aaron Siri, has previously petitioned the FDA to revoke approval of the polio vaccine, citing insufficient safety studies. This move has sparked controversy and concern among public health experts and politicians, with Senate Minority Leader Mitch McConnell, a polio survivor, defending the vaccine's lifesaving impact. Trump has also voiced concerns about the link between vaccines and autism, driving the need for this review. The review could lead to significant changes in vaccine policy, potentially affecting public health initiatives and vaccination programs across the country.
View original story
Similar markets
Minor issues found • 25%
Significant issues found • 25%
No issues found • 25%
Undetermined • 25%
Increased studies • 25%
No change • 25%
Other actions • 25%
Revised guidelines • 25%
No action taken • 25%
Issue new safety guidelines • 25%
Conduct further studies • 25%
Other actions • 25%
Vaccines not linked to autism • 25%
Vaccines linked to autism • 25%
Investigation not completed • 25%
Inconclusive results • 25%
Complete overhaul of vaccination program • 25%
No changes to current vaccination program • 25%
Reduction in number of vaccines • 25%
Introduction of new vaccine safety measures • 25%
Inconclusive results • 25%
Link found • 25%
Investigation not completed • 25%
No link found • 25%
Investigation incomplete • 25%
Vaccines linked to autism • 25%
Vaccines not linked to autism • 25%
Investigation not completed • 25%
No report released • 25%
Inconclusive results • 25%
Link found • 25%
No link found • 25%
Inconclusive • 25%
Confirms link • 25%
Yes • 50%
No • 50%
Rejected • 25%
Withdrawn • 25%
No decision • 25%
Approved • 25%
Guideline updates • 25%
Further studies commissioned • 25%
Vaccine suspension or recall • 25%
No significant action • 25%
